Entrada Therapeutics Inc (TRDA)
14.25
+0.08
(+0.56%)
USD |
NASDAQ |
Jun 28, 16:00
14.36
+0.11
(+0.77%)
Pre-Market: 20:00
Entrada Therapeutics Shares Outstanding: 33.76M for April 30, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 30, 2024 | 33.76M |
April 16, 2024 | 33.68M |
March 31, 2024 | 33.60M |
March 06, 2024 | 33.60M |
December 31, 2023 | 33.44M |
October 31, 2023 | 33.37M |
September 30, 2023 | 33.34M |
July 31, 2023 | 33.27M |
June 30, 2023 | 33.21M |
April 30, 2023 | 33.20M |
April 11, 2023 | 33.19M |
March 31, 2023 | 33.18M |
February 28, 2023 | 33.08M |
February 09, 2023 | 33.02M |
December 31, 2022 | 31.39M |
Date | Value |
---|---|
October 31, 2022 | 31.41M |
September 30, 2022 | 31.33M |
July 31, 2022 | 31.37M |
June 30, 2022 | 31.28M |
April 30, 2022 | 31.37M |
April 05, 2022 | 31.36M |
March 31, 2022 | 31.26M |
February 28, 2022 | 31.25M |
December 31, 2021 | 31.22M |
November 30, 2021 | 31.21M |
November 05, 2021 | 31.25M |
November 02, 2021 | 29.89M |
October 29, 2021 | 29.89M |
October 25, 2021 | 28.31M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
28.31M
Minimum
Oct 25 2021
33.76M
Maximum
Apr 30 2024
32.09M
Average
31.41M
Median
Oct 31 2022
Shares Outstanding Benchmarks
Catalyst Pharmaceuticals Inc | 118.12M |
Vertex Pharmaceuticals Inc | 258.05M |
Sarepta Therapeutics Inc | 94.52M |
PTC Therapeutics Inc | 76.70M |
GlycoMimetics Inc | 64.46M |